Valora unveils a sweet way to stop cancer & autoimmune disease

The latest stories trending on MedCity News.

Editor's Pick

Top Story Startup Valora Unveils a Sweet Way to Stop Cancer and Autoimmune Disease, Plus $30M for R&D Valora Therapeutics' antibody lectin chimeras, or AbLecs, target glyco-immune checkpoints, pathways that modulate cellular communication with the immune system. The startup's science is based on research from Carolyn Bertozzi, a Stanford professor who was awarded the 2022 Nobel Prize in Chemistry. Sponsored MedCity Pivot Podcast: How Employers are Tackling GLP-1 Coverage Presented by Personify Health In a conversation with MedCity News, Personify Health Chief Medical Officer Jeff Jacques talks about the different types of GLP-1 drugs, what portion of employers currently offer the medications, and how many employers are considering making them part of their health benefit offering in the future. Click here for the full episode. INVEST 2025: Connect with Investors, Startups, and Healthcare Leaders Driving Change Create opportunities in healthcare innovation by attending INVEST in Chicago, 29-30 April, 2025. Secure your spot and lock in the best rate before December 13th. Register Now for Extreme Early Bird Rate

Featured News

Orion Innovations' Light-Up Infusion Device Helps Both Patients and Nurses, Research Shows A Utah-based startup named Orion Innovations released two studies this month demonstrating its product's efficacy. The device attaches to hospital IV lines and uses a light to assist nurses with the identification and tracing of medication infusion lines, with the goal of reducing errors. World Class Health Snags $8M To Expand Global Centers of Excellence Network World Class Health's $8 million in seed funding was led by AlleyCorp. The company serves self-funded employers and offers access to a global centers of excellence network. Family Caregivers Deserve to be a Valued Part of the Healthcare Continuum  Ensuring that family caregivers, and hospice providers all get the support that they need is more than just about ensuring that a patient receives end-of-life care with the dignity and support they deserve. Polypharmacy is a Health Killer: Personalized Medication Management is the Answer We cannot change the fact that some patients must take multiple drugs, but we can certainly change how we manage it with careful coordination and communication among healthcare providers, and personalized medicine practices such as pharmacogenomics.

Resources

SPONSORED 5 Top-Rated Electronic Medical Records Software for SMBs This report can help small and midsize businesses compare the five top-rated Electronic Medical Record (EMR) software solutions, and offers insights into: Verified user reviews about EMR software Key features of EMR software Actionable recommendations for SMBs to choose the right software Download Free Guide Now

MedCity News • PO Box 901 • New York, NY unsubscribe